John Teerlink, MD: Impact of COVID-19 on Clinical Trials

preview_player
Показать описание
Professor of Medicine and Executive Committee Chair, COSMIC-HF and GALACTIC-HF discusses impact of COVID-19 on clinical trials.
  1. HCPLive
  2. covid-19
  3. clincal trials
  4. fda
Рекомендации по теме
John Teerlink, MD: 0:03:56

John Teerlink, MD: Impact of COVID-19 on Clinical Trials

John Teerlink, MD: 0:07:17

John Teerlink, MD: GALACTIC-HF Patient Population

The Relax-AHF-2 Trial: 0:08:49

The Relax-AHF-2 Trial: Dr John Teerlink (HFA Congress 2017 - Paris)

#HFSA2019 TV: Interview 0:04:36

#HFSA2019 TV: Interview with John Teerlink, MD

Serelaxin in Acute 0:08:18

Serelaxin in Acute Heart Failure

Late Breaking Trials 0:08:45

Late Breaking Trials on Heart Failure and Acute Coronary Syndrome: J. TEERLINK (San Francisco):

J. Teerlink - 0:07:04

J. Teerlink - The RELAXin in Acute Heart Failure (RELAX-AHF-1) Trial

COSMIC-HF: Omecamtiv Mecarbil 0:09:15

COSMIC-HF: Omecamtiv Mecarbil in Chronic Heart Failure

GALACTIC-HF Results 0:05:39

GALACTIC-HF Results

AHA 2015 | 0:04:29

AHA 2015 | COSMIC-HF

Webinar 'Landmark trials 1:08:11

Webinar 'Landmark trials in heart failure'

The impact of 0:02:01

The impact of COVID-19 on clinical research and development

Hyperkalemia TV: A 0:00:57

Hyperkalemia TV: A Team Mindset for Optimizing HF Therapy

ESC TV 2013 0:06:59

ESC TV 2013 - Hotline IV: AQUARIUS and ATOMIC AHF

Webinar | JACC: 0:50:31

Webinar | JACC: Heart Failure December Virtual Journal Club - Discussion on the STAND-UP AHF Study

Professor John McMurray 0:29:48

Professor John McMurray - Heart failure therapy – extending the limits!

Episode 6: Implications 0:55:54

Episode 6: Implications of the Advisory Committee Meetings for the Heart Failure Community

JACC: Heart Failure 0:51:05

JACC: Heart Failure Journal Club | June 18, 2020

RELAX-AHF-2 Serelaxin in 0:01:26

RELAX-AHF-2 Serelaxin in acute heart failure

New Medication Shows 0:11:31

New Medication Shows Early Promise for Heart Failure Treatment

Endpoints in Heart 1:00:44

Endpoints in Heart Failure Clinical Trials: Challenges and Potential Resolutions

GALACTIC-HF Subgroup Analysis: 0:02:56

GALACTIC-HF Subgroup Analysis: Omecamtiv Mecarbil Effective Across Ethnic Groups | Dr David Lanfear

GALACTIC HF Trial: 0:04:05

GALACTIC HF Trial: Omecamtiv mecarbil

Spotlight On...COVID-19’s Impact 0:06:19

Spotlight On...COVID-19’s Impact on Quality in Clinical Trials